{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:56:25Z","timestamp":1792065385832,"version":"4.4.0"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","soard.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery for Obesity and Related Diseases"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.soard.2026.09.020","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:34:44Z","timestamp":1790688884000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Obesity treatment access in the United States: a state-level scorecard"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5619-7637","authenticated-orcid":false,"given":"John David","family":"Scott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allyson Lynn","family":"Hale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6301-3958","authenticated-orcid":false,"given":"Tracy","family":"Zvenyach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Nadglowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7549-4135","authenticated-orcid":false,"given":"Lisa Renee","family":"Hilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.soard.2026.09.020_bib1","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/obr.12551","article-title":"Obesity: a chronic relapsing progressive disease process: a position statement of the World obesity Federation","volume":"18","author":"Bray","year":"2017","journal-title":"Obes Rev"},{"key":"10.1016\/j.soard.2026.09.020_bib2","series-title":"Obesity and severe obesity prevalence in adults: United States, August 2021\u2013August 2023. NCHS Data Brief No. 508","author":"Emmerich","year":"2024"},{"issue":"9669","key":"10.1016\/j.soard.2026.09.020_bib5","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0140-6736(09)60318-4","article-title":"Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies","volume":"373","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.soard.2026.09.020_bib6","series-title":"State of Obesity 2024: Better Policies for a Healthier America","year":"2024"},{"key":"10.1016\/j.soard.2026.09.020_bib9","series-title":"Medicaid obesity treatment coverage 2024","year":"2024"},{"issue":"7","key":"10.1016\/j.soard.2026.09.020_bib11","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1007\/s11606-025-10012-y","article-title":"Medicaid coverage and prior authorization for antiobesity glucagon-like peptide-1 receptor agonists: a cross-sectional study of state policies","volume":"41","author":"Klebanoff","year":"2026","journal-title":"J Gen Intern Med"},{"issue":"2","key":"10.1016\/j.soard.2026.09.020_bib27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00005650-198102000-00001","article-title":"The concept of access: definition and relationship to consumer satisfaction","volume":"19","author":"Penchansky","year":"1981","journal-title":"Med Care"},{"key":"10.1016\/j.soard.2026.09.020_bib28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1475-9276-12-18","article-title":"Patient-centred access to health care: conceptualising access at the interface of health systems and populations","volume":"12","author":"Levesque","year":"2013","journal-title":"Int J Equity Health"},{"issue":"4","key":"10.1016\/j.soard.2026.09.020_bib29","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2337\/cd24-0115","article-title":"Navigating cost and access barriers for medications in the treatment of obesity: a guide for patients and primary care clinicians","volume":"43","author":"Herges","year":"2025","journal-title":"Clin Diabetes"},{"issue":"12","key":"10.1016\/j.soard.2026.09.020_bib30","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/oby.23556","article-title":"Addressing insurance-related barriers to novel antiobesity medications: lessons to be learned from bariatric surgery","volume":"30","author":"Gasoyan","year":"2022","journal-title":"Obesity (Silver Spring)"},{"issue":"7","key":"10.1016\/j.soard.2026.09.020_bib31","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s40273-015-0264-0","article-title":"The challenges and opportunities associated with reimbursement for obesity pharmacotherapy in the USA","volume":"33","author":"Baum","year":"2015","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"10.1016\/j.soard.2026.09.020_bib32","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ijo.2017.287","article-title":"US health policy and prescription drug coverage of FDA-approved medications for the treatment of obesity","volume":"42","author":"Gomez","year":"2018","journal-title":"Int J Obes (Lond)"},{"issue":"2","key":"10.1016\/j.soard.2026.09.020_bib33","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.gtc.2023.02.003","article-title":"Disparities in access and quality of obesity care","volume":"52","author":"Washington","year":"2023","journal-title":"Gastroenterol Clin North Am"},{"issue":"3","key":"10.1016\/j.soard.2026.09.020_bib34","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41366-021-01024-9","article-title":"A national evaluation of geographic accessibility and provider availability of obesity medicine diplomates in the United States between 2011 and 2019","volume":"46","author":"Pollack","year":"2022","journal-title":"Int J Obes (Lond)"}],"container-title":["Surgery for Obesity and Related Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550728926009263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550728926009263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:31:33Z","timestamp":1792063893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1550728926009263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":14,"alternative-id":["S1550728926009263"],"URL":"https:\/\/doi.org\/10.1016\/j.soard.2026.09.020","relation":{},"ISSN":["1550-7289"],"issn-type":[{"value":"1550-7289","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obesity treatment access in the United States: a state-level scorecard","name":"articletitle","label":"Article Title"},{"value":"Surgery for Obesity and Related Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soard.2026.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Metabolic and Bariatric Surgery. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}